2012
DOI: 10.1016/j.jacc.2011.09.022
|View full text |Cite
|
Sign up to set email alerts
|

Hypoplastic Left Heart Syndrome

Abstract: In the recent era, no congenital heart defect has undergone a more dramatic change in diagnostic approach, management, and outcomes than hypoplastic left heart syndrome (HLHS). During this time, survival to the age of 5 years (including Fontan) has ranged from 50% to 69%, but current expectations are that 70% of newborns born today with HLHS may reach adulthood. Although the 3-stage treatment approach to HLHS is now well founded, there is significant variation among centers. In this white paper, we present the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
174
0
2

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 426 publications
(179 citation statements)
references
References 463 publications
(546 reference statements)
2
174
0
2
Order By: Relevance
“…Although the Fontan procedure has significantly improved early survival, transplant-free 30-year survival remains at only 60 % [7]. These patients can also experience significant long-term complications including heart failure, protein-losing enteropathy, and plastic bronchitis [8]. The pathophysiology of these complications is poorly understood, but may be linked to limited pulmonary artery growth, low-shear non-pulsatile pulmonary blood flow (PBF), and thrombus formation leading to increased pulmonary vascular resistance (PVR) [18].…”
Section: Introductionmentioning
confidence: 99%
“…Although the Fontan procedure has significantly improved early survival, transplant-free 30-year survival remains at only 60 % [7]. These patients can also experience significant long-term complications including heart failure, protein-losing enteropathy, and plastic bronchitis [8]. The pathophysiology of these complications is poorly understood, but may be linked to limited pulmonary artery growth, low-shear non-pulsatile pulmonary blood flow (PBF), and thrombus formation leading to increased pulmonary vascular resistance (PVR) [18].…”
Section: Introductionmentioning
confidence: 99%
“…Today, interstage mortality ranges between 2% and 20% with almost 75% of deaths occurring suddenly. 2,7,8 In recognition of this, in 2011, the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) focused on improvement in interstage mortality. 9 Today, a large majority of programs use home monitoring during the interstage period.…”
Section: The Interstage Periodmentioning
confidence: 99%
“…Hospital mortality after the Norwood procedure remains the highest among common congenital heart procedures, ranging between 7% and 19%. 2,3 An analysis of resource utilization for common structural heart defects has shown that the Norwood procedure is associated with the highest cost, and the third longest length of stay. 4 …”
mentioning
confidence: 99%
“…With regard to HLHS palliative surgery and the valuable insight that can be gathered experimentally, MCLs can be modified to incorporate the effect of respiration [21] which becomes relevant when these patients receive their second and third surgeries, i.e. the Glenn procedure and the total cavopulmonary connect (or Fontan completion) [22]. A system incorporating a patient-specific 3D-printed Fontan model has indeed been realised [23].…”
Section: Multi-scale Hydrodynamic Setups: Studying Single Ventricle Pmentioning
confidence: 99%